

CABENUVA (cabotegravir 200 mg/mL; rilpivirine 300 mg/mL) EXTENDED-RELEASE INJECTABLE SUSPENSIONS: PATIENT ASSISTANCE PROGRAM (PAP)*
Photography is being used for illustrative purposes only. Stock photo. Posed by model.
The ViiV Healthcare Patient Assistance Program (PAP) offers our medicines at no cost to patients who qualify.
At ViiV Healthcare, we strive to provide an equal standard of care for all patients. If a patient doesn’t have insurance and is having trouble paying for the ViiV Healthcare medicine(s) prescribed, the patient may qualify for PAP.
To be eligible for PAP, the patient MUST:
- Live in one of the 50 states, the District of Columbia, or Puerto Rico
- Have a household income less than or equal to 500% of the Federal Poverty Level based on household size
- Not be eligible for Medicaid or Puerto Rico’s Government Health Plan, Mi Salud
And either:
- Have no prescription drug coverage,
Or:
- Have a Medicare Part B, Medicare Part D, or Medicare Advantage Plan and have spent at least $600 or more on out-of-pocket prescription expenses during the current calendar year,
Or:
- Have a private insurance plan limited to generic-only coverage, outpatient use only, or therapeutic class exclusion (non-coverage) of drug
NOTE: Puerto Rico applicants who qualify for Puerto Rico’s Government Health Plan must have documentation of denial of coverage through Mi Salud before applying to ViiV Healthcare PAP.
*Subject to eligibility, program terms and conditions. ViiVConnect programs do not constitute health insurance.
PAP Frequently Asked Questions
Collapse All

NEED HELP? TALK ONE-ON-ONE LIVE WITH OUR ACCESS COORDINATORS
1-844-588-3288 (toll free)
We have programs for eligible patients who are insured, underinsured, and uninsured.
Monday - Friday, 8AM - 11PM (ET).
Multilingual options available.
CBRPSP190017